358570.KQ KOE
GI Innovation, Inc.
1W: -0.6%
1M: +11.8%
3M: -11.6%
YTD: -39.1%
1Y: -53.1%
3Y: -2.2%
₩8,820.00 ($6.53)
-720.00 (-7.55%)
Weekly Expected Move ±15.0%
₩6167
₩7493
₩8820
₩10147
₩11473
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩566.5B ($419.2M)
52W Range6470-20950
Volume413,299
Avg Volume628,422
Beta0.43
Dividend—
Analyst Ratings
No analyst coverage
Company Info
Room 1116 of A-dong, Songpa-daero 167
Seoul, SL 5855
KR
Seoul, SL 5855
KR
+82 2 404 2003
About GI Innovation, Inc.
GI Innovation, Inc. specializes in the research and creation of biopharmaceutical products. Its current developmental portfolio features drug candidates G-101, G-102, G-301, and G-108. Founded by Jang Myoung-ho on July 19, 2017, the company's main operations are situated in Seoul, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found